神经外科治疗治疗耐药抑郁症的比较副作用
Alexandre Lim Eng Keat1, Keith Tan Jian Li1, Teo Chuin Hau1
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
CNS neuroscience & therapeutics
|October 29, 2024
概括
神经外科提供了治疗耐药性抑郁症 (TRD) 的选择,但具有副作用. 本综述详细介绍了与TRD神经外科治疗相关的风险,如失禁,头痛和语音问题.
科学领域:
- 神经外科 神经外科
- 精神病学是一个精神病学.
- 神经学 神经学
背景情况:
- 耐治疗性抑郁症 (TRD) 影响那些对标准抗抑郁药物治疗没有反应的患者.
- 对TRD进行神经外科干预,包括除性手术,深度大脑刺激和迷走神经刺激等.
- 了解神经外科副作用对于评估TRD治疗疗效至关重要.
研究的目的:
- 审查和总结用于抑郁症临床研究的神经外科手术程序的副作用概况.
- 为 TRD 提供与除性手术,深度大脑刺激和迷走神经刺激相关的不良事件的概述.
主要方法:
- 在主要数据库中进行了全面的文献搜索:PubMed,MEDLINE,EMBASE,Ovid和ClinicalTrials.gov.gov.
- 涉及神经外科干预抑郁症的研究被系统地确定和审查.
主要成果:
- 分析包括10项关于除性手术的研究,12项关于深度大脑刺激的研究,10项关于TRD的迷走神经刺激的研究.
- 确定的副作用是:消除性手术 (失禁,困惑),深度大脑刺激 (头痛,增加自杀念头) 和迷走神经刺激 (声音,呼吸障碍).
结论:
- 神经外科作为TRD治疗方式具有好处和缺点.
- 需要进一步的研究,以减轻神经外科副作用,提高它们的可行性和有效性,用于TRD管理.
相关概念视频
Psychosurgery
46
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
46
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
320
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
320


